Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 193

1.

Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.

Hashemi-Sadraei N, Müller-Greven GM, Abdul-Karim FW, Ulasov I, Downs-Kelly E, Burgett ME, Lauko A, Qadan MA, Weil RJ, Ahluwalia MS, Du L, Prayson RA, Chao ST, Budd TG, Barnholtz-Sloan J, Nowacki AS, Keri RA, Gladson CL.

J Neurooncol. 2018 Nov;140(2):237-248. doi: 10.1007/s11060-018-2959-5. Epub 2018 Aug 9.

PMID:
30094720
2.

Thickened Endometrium in Postmenopausal Women With an Initial Biopsy of Limited, Benign, Surface Endometrium: Clinical Outcome and Subsequent Pathologic Diagnosis.

Dermawan JKT, Hur C, Uberti MG, Flyckt R, Falcone T, Brainard J, Abdul-Karim FW.

Int J Gynecol Pathol. 2018 May 10. doi: 10.1097/PGP.0000000000000525. [Epub ahead of print]

PMID:
29750705
3.

CD55 regulates self-renewal and cisplatin resistance in endometrioid tumors.

Saygin C, Wiechert A, Rao VS, Alluri R, Connor E, Thiagarajan PS, Hale JS, Li Y, Chumakova A, Jarrar A, Parker Y, Lindner DJ, Nagaraj AB, Kim JJ, DiFeo A, Abdul-Karim FW, Michener C, Rose PG, DeBernardo R, Mahdi H, McCrae KR, Lin F, Lathia JD, Reizes O.

J Exp Med. 2017 Sep 4;214(9):2715-2732. doi: 10.1084/jem.20170438. Epub 2017 Aug 24.

4.

Cytologic-Histologic Discrepancies in Pathology of the Uterine Cervix: Analysis of the Clinical and Pathologic Factors.

Abdul-Karim FW, Yang B.

Adv Anat Pathol. 2017 Sep;24(5):304-309. doi: 10.1097/PAP.0000000000000165. Review.

PMID:
28777141
5.

Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer.

Seachrist DD, Sizemore ST, Johnson E, Abdul-Karim FW, Weber Bonk KL, Keri RA.

Breast Cancer Res. 2017 Jun 5;19(1):66. doi: 10.1186/s13058-017-0857-y.

6.

Interobserver agreement in the cytologic grading of atypia in neoplastic pancreatic mucinous cysts with the 2-tiered approach.

Goyal A, Abdul-Karim FW, Yang B, Patel JB, Brainard JA.

Cancer Cytopathol. 2016 Dec;124(12):909-916. doi: 10.1002/cncy.21767. Epub 2016 Aug 15.

7.
8.

Abrupt loss of MLH1 and PMS2 expression in endometrial carcinoma: molecular and morphologic analysis of 6 cases.

Pai RK, Plesec TP, Abdul-Karim FW, Yang B, Marquard J, Shadrach B, Roma AR.

Am J Surg Pathol. 2015 Jul;39(7):993-9. doi: 10.1097/PAS.0000000000000415.

PMID:
25786082
9.

p16 Immunohistochemistry is useful in confirming high-grade squamous intraepithelial lesions (HSIL) in women with negative HPV testing.

Zhang G, Yang B, Abdul-Karim FW.

Int J Gynecol Pathol. 2015 Mar;34(2):180-6. doi: 10.1097/PGP.0000000000000112.

PMID:
25675189
10.

Combined SFK/mTOR inhibition prevents rapamycin-induced feedback activation of AKT and elicits efficient tumor regression.

Yori JL, Lozada KL, Seachrist DD, Mosley JD, Abdul-Karim FW, Booth CN, Flask CA, Keri RA.

Cancer Res. 2014 Sep 1;74(17):4762-71. doi: 10.1158/0008-5472.CAN-13-3627. Epub 2014 Jul 14.

11.

Papanicolaou tests with coexisting squamous and glandular abnormalities.

Khor LY, Abdul-Karim FW, Bruening AE, Weber Noffsinger DK, Booth CN.

Cancer Cytopathol. 2014 Aug;122(8):620-6. doi: 10.1002/cncy.21448. Epub 2014 Jun 17.

12.

Hypomethylation of the MMP7 promoter and increased expression of MMP7 distinguishes the basal-like breast cancer subtype from other triple-negative tumors.

Sizemore ST, Sizemore GM, Booth CN, Thompson CL, Silverman P, Bebek G, Abdul-Karim FW, Avril S, Keri RA.

Breast Cancer Res Treat. 2014 Jul;146(1):25-40. doi: 10.1007/s10549-014-2989-4. Epub 2014 May 22.

13.

ASPL-TFE3 translocation in vulvovaginal alveolar soft part sarcoma.

Jabbour MN, Seoud M, Al-Ahmadie H, Abdul-Karim FW, Zaatari GS.

Int J Gynecol Pathol. 2014 May;33(3):263-7. doi: 10.1097/PGP.0b013e318290407c. Review.

PMID:
24681737
14.

Inconclusive or erroneous fine-needle aspirates of breast with adequate and representative material: a cytologic/histologic study.

Shabb NS, Boulos FI, Chakhachiro Z, Abbas J, Abdul-Karim FW.

Diagn Cytopathol. 2014 May;42(5):405-15. doi: 10.1002/dc.23054. Epub 2013 Oct 25.

PMID:
24167007
15.

Indeterminate and erroneous fine-needle aspirates of breast with focus on the 'true gray zone': a review.

Shabb NS, Boulos FI, Abdul-Karim FW.

Acta Cytol. 2013;57(4):316-31. doi: 10.1159/000351159. Epub 2013 Jul 12.

16.

MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer.

Siroy A, Abdul-Karim FW, Miedler J, Fong N, Fu P, Gilmore H, Baar J.

Hum Pathol. 2013 Oct;44(10):2159-66. doi: 10.1016/j.humpath.2013.04.010. Epub 2013 Jul 8.

17.

FOXC1 is enriched in the mammary luminal progenitor population, but is not necessary for mouse mammary ductal morphogenesis.

Sizemore GM, Sizemore ST, Pal B, Booth CN, Seachrist DD, Abdul-Karim FW, Kume T, Keri RA.

Biol Reprod. 2013 Jul 11;89(1):10. doi: 10.1095/biolreprod.113.108001. Print 2013 Jul.

18.

Ribonucleotide reductase expression in cervical cancer: a radiation therapy oncology group translational science analysis.

Kunos CA, Winter K, Dicker AP, Small W Jr, Abdul-Karim FW, Dawson D, Jhingran A, Valicenti R, Weidhaas JB, Gaffney DK.

Int J Gynecol Cancer. 2013 May;23(4):615-21. doi: 10.1097/IGC.0b013e31828b4eb5.

19.

Elevated ribonucleotide reductase levels associate with suppressed radiochemotherapy response in human cervical cancers.

Kunos CA, Radivoyevitch T, Kresak A, Dawson D, Jacobberger J, Yang B, Abdul-Karim FW.

Int J Gynecol Cancer. 2012 Nov;22(9):1463-9. doi: 10.1097/IGC.0b013e318270577f.

20.

Testicular fibroma.

Jabbour MN, Zaatari GS, Tfayli AH, Abdul-Karim FW.

J Urol. 2012 Nov;188(5):1944-5. doi: 10.1016/j.juro.2012.08.057. Epub 2012 Sep 20. No abstract available.

PMID:
22999552

Supplemental Content

Loading ...
Support Center